Over 50s COVID-19 trial launches across UK
PRINCIPLE is looking at whether existing drugs can be repurposed for older patients in the community who show signs of the disease
Read More
Tag: PRINCIPLE
Nationwide launch for GP-based trial of COVID-19 therapies
Study aiming to enrol 3,000 patients via more than 100 GP surgeries
Read More
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
